These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 26054690

  • 1. miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor.
    Wei R, Deng Z, Su J.
    Biomed Pharmacother; 2015 May; 72():158-64. PubMed ID: 26054690
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
    Zhou H, Zhang M, Yuan H, Zheng W, Meng C, Zhao D.
    Oncol Rep; 2016 Mar; 35(3):1851-8. PubMed ID: 26708300
    [Abstract] [Full Text] [Related]

  • 3. MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma.
    Yang G, Zhang P, Lv A, Liu Y, Wang G.
    Exp Mol Pathol; 2016 Feb; 100(1):160-6. PubMed ID: 26708425
    [Abstract] [Full Text] [Related]

  • 4. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z, Jiang C, Fang J.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):238-245. PubMed ID: 29108989
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
    Bao Y, Chen B, Wu Q, Hu K, Xi X, Zhu W, Zhong X, Chen J.
    Clin Exp Med; 2017 Feb 01; 17(1):51-58. PubMed ID: 26515813
    [Abstract] [Full Text] [Related]

  • 6. miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression.
    Gao Y, Luo LH, Li S, Yang C.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):230-4. PubMed ID: 24462867
    [Abstract] [Full Text] [Related]

  • 7. miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2.
    Yang C, Hou C, Zhang H, Wang D, Ma Y, Zhang Y, Xu X, Bi Z, Geng S.
    Int J Mol Sci; 2013 Dec 31; 15(1):423-37. PubMed ID: 24384842
    [Abstract] [Full Text] [Related]

  • 8. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
    Du JY, Wang LF, Wang Q, Yu LD.
    Oncol Rep; 2015 Apr 31; 33(4):1890-8. PubMed ID: 25672572
    [Abstract] [Full Text] [Related]

  • 9. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, Minami Y.
    Oncogene; 2009 Sep 10; 28(36):3197-208. PubMed ID: 19561643
    [Abstract] [Full Text] [Related]

  • 10. miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.
    Li Z, Li Y, Wang N, Yang L, Zhao W, Zeng X.
    Biochem Biophys Res Commun; 2016 Mar 18; 471(4):479-85. PubMed ID: 26902120
    [Abstract] [Full Text] [Related]

  • 11. MiR-26a inhibits prostate cancer progression by repression of Wnt5a.
    Zhao S, Ye X, Xiao L, Lian X, Feng Y, Li F, Li L.
    Tumour Biol; 2014 Oct 18; 35(10):9725-33. PubMed ID: 24972966
    [Abstract] [Full Text] [Related]

  • 12. miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.
    Wu P, Liang J, Yu F, Zhou Z, Tang J, Li K.
    Oncotarget; 2016 Jul 05; 7(27):42241-42251. PubMed ID: 27304058
    [Abstract] [Full Text] [Related]

  • 13. RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1).
    Zhao X, Wang Q, Lin F, Wang X, Wang Y, Wang J, Wang C.
    Med Sci Monit; 2019 Jul 05; 25():4982-4991. PubMed ID: 31276465
    [Abstract] [Full Text] [Related]

  • 14. miR-155 promotes the growth of osteosarcoma in a HBP1-dependent mechanism.
    Sun X, Geng X, Zhang J, Zhao H, Liu Y.
    Mol Cell Biochem; 2015 May 05; 403(1-2):139-47. PubMed ID: 25666090
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.